2 Minute Medicine Rewind September 2, 2024
Repetitive Head Impacts and Perivascular Space Volume in Former American Football Players 1. In a cohort of former American football ...
Tag: oncology
Medication-related osteonecrosis of the jaw is prevalent in patients with breast cancer
1. The cumulative incidence of medication-related osteonecrosis of the jaw (MRONJ) in patients with breast cancer bone metastases was much ...
Brentuximab-based chemotherapy improves survival and reduces toxicity in patients with advanced Hodgkin lymphoma
1. BrECADD resulted in significantly lower treatment-related morbidity than eBEACOPP. 2. Progression-free survival at 48 months was significantly greater in ...
#VisualAbstract Molecular Guided Therapy Improves Survival for Unfavourable Cancer of Unknown Origin
Click here to read this study in Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
Dose-dense adjuvant therapy with epirubicin and cyclophosphamide effective for breast cancer
1. Dose-dense adjuvant chemotherapy involving sequential epirubicin/cyclophosphamide and docetaxel showed improved breast cancer recurrence-free survival and event-free survival compared to ...
Phase I trial of novel CAR-T cell therapy for pediatric midline gliomas
1. Approximately 88% of patients with GD2-positive diffuse midline glioma or other progressive CNS tumours receiving C7R-GD2.CARTs had a partial ...
#VisualAbstract Bilateral Masectomy Reduces Risk of Contralateral Breast Cancer But Does Not Reduce the Breast Cancer Mortality Rate
Click here to read this study in the NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
2 Minute Medicine Rewind August 5, 2024
Digital Storytelling Intervention for Hemoglobin A1c Control Among Hispanic Adults With Type 2 Diabetes 1. The use of a digital ...
Sintilimab improves survival in advanced non-metastatic nasopharyngeal carcinoma
1. Patients in the sintilimab group reported a significantly greater event-free survival at 36 months compared to the standard therapy ...
#VisualAbstract Amivantamab-lazertinib is Effective for Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...